These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8596941)

  • 1. Attenuated HIV vaccine: caveats.
    Ruprecht RM; Baba TW; Liska V
    Science; 1996 Mar; 271(5257):1790-2. PubMed ID: 8596941
    [No Abstract]   [Full Text] [Related]  

  • 2. Characterization of simian and human immunodeficiency chimeric viruses re-isolated from vaccinated macaque monkeys after challenge infection.
    Kwofie TB; Miura T; Ibuki K; Enose Y; Suzuki H; Ui M; Kuwata T; Hayami M
    Arch Virol; 2002 Jun; 147(6):1091-104. PubMed ID: 12111421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS vaccine development in primate models.
    Almond NM; Heeney JL
    AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
    [No Abstract]   [Full Text] [Related]  

  • 4. HIV with multiple gene deletions as a live attenuated vaccine for AIDS.
    Desrosiers RC
    AIDS Res Hum Retroviruses; 1992 Aug; 8(8):1457. PubMed ID: 1466981
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety issues facing development of a live-attenuated, multiply deleted HIV-1 vaccine.
    Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 Apr; 10(4):331-2. PubMed ID: 8068412
    [No Abstract]   [Full Text] [Related]  

  • 6. Properties of a chimeric simian-human immunodeficiency virus expressing an hybrid HIV-1 Nef/SIVmac Nef protein.
    Bertsch C; Cluet D; Beyer C; Gloeckler L; Cecile A; Gut JP; Aubertin AM
    Arch Virol; 2002 Oct; 147(10):1963-75. PubMed ID: 12376757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Live attenuated AIDS viruses as vaccines: promise or peril?
    Ruprecht RM
    Immunol Rev; 1999 Aug; 170():135-49. PubMed ID: 10566148
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AIDS vaccine models: challenging challenge viruses.
    Feinberg MB; Moore JP
    Nat Med; 2002 Mar; 8(3):207-10. PubMed ID: 11875482
    [No Abstract]   [Full Text] [Related]  

  • 9. Mucosal transmission of virulent and avirulent lentiviruses in macaques.
    Pauza CD; Horejsh D; Wallace M
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S83-7. PubMed ID: 9581890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV/AIDS in China. Vaccine development with a distinctly Chinese flavor.
    Cohen J
    Science; 2004 Jun; 304(5676):1437. PubMed ID: 15178780
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel strategies toward the development of an effective vaccine to prevent human immunodeficiency virus infection or acquired immunodeficiency virus.
    Ensoli B; Cafaro A
    AIDS Clin Rev; 2000-2001; ():23-61. PubMed ID: 10999215
    [No Abstract]   [Full Text] [Related]  

  • 12. Immunotherapy for AIDS virus infections: cautious optimism for cell-based vaccine.
    Bhardwaj N; Walker BD
    Nat Med; 2003 Jan; 9(1):13-4. PubMed ID: 12514710
    [No Abstract]   [Full Text] [Related]  

  • 13. A conditionally replicating virus as a novel approach toward an HIV vaccine.
    Das AT; Verhoef K; Berkhout B
    Methods Enzymol; 2004; 388():359-79. PubMed ID: 15289083
    [No Abstract]   [Full Text] [Related]  

  • 14. Live attenuated HIV vaccines: pitfalls and prospects.
    Whitney JB; Ruprecht RM
    Curr Opin Infect Dis; 2004 Feb; 17(1):17-26. PubMed ID: 15090885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope.
    Barnett SW; Srivastava IK; Kan E; Zhou F; Goodsell A; Cristillo AD; Ferrai MG; Weiss DE; Letvin NL; Montefiori D; Pal R; Vajdy M
    AIDS; 2008 Jan; 22(3):339-48. PubMed ID: 18195560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronology of genetic changes in the vpu, env, and Nef genes of chimeric simian-human immunodeficiency virus (strain HXB2) during acquisition of virulence for pig-tailed macaques.
    McCormick-Davis C; Zhao LJ; Mukherjee S; Leung K; Sheffer D; Joag SV; Narayan O; Stephens EB
    Virology; 1998 Sep; 248(2):275-83. PubMed ID: 9721236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1999: a time to re-evaluate AIDS vaccine strategies.
    Ruprecht RM; Hofmann-Lehmann R; Rasmussen RA; Vlasak J; Xu W
    J Hum Virol; 2000; 3(2):88-93. PubMed ID: 10850895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated retrovirus vaccines and AIDS.
    Marx PA
    Science; 1995 Nov; 270(5239):1219-20; author reply 1220-2. PubMed ID: 7502054
    [No Abstract]   [Full Text] [Related]  

  • 19. Nef and PAK: virulence factor and cellular accomplice.
    Trono D; Wang JK
    Chem Biol; 1997 Jan; 4(1):13-5. PubMed ID: 9070423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the Nef protein of HIV-1 required for pathogenesis?
    Miller MD; Greene WC
    Trends Microbiol; 1996 May; 4(5):171-2; discussion 173. PubMed ID: 8727595
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.